SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (1275)2/1/2000 9:25:00 AM
From: scaram(o)ucheRead Replies (1) of 4974
 
>> Looks like the window may be closing here. <<

Big wind from south blows door open, even if window was tempered.....

Tuesday February 1, 6:30 am Eastern Time

Company Press Release

SOURCE: Sequenom, Inc.

Sequenom Commences Initial Public Offering of
Common Stock

SAN DIEGO, Feb. 1 /PRNewswire/ -- Sequenom, Inc. (Nasdaq: SQNM - news) announced today that it has commenced an
initial public offering of 5,250,000 shares of its common stock at a price of $26 per share that is lead managed by Warburg
Dillon Read LLC. Robertson Stephens and SG Cowen will also manage the offering. The underwriters will be granted a
30-day over-allotment option to purchase up to 787,500 additional shares of common stock from the Company at a price of
$26 per share.

(snip)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News